Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug Resistance Updates | journal | 4.391 Q1 | 132 | 28 | 65 | 5855 | 1577 | 65 | 23.73 | 209.11 | |
2 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.657 Q1 | 159 | 132 | 323 | 21120 | 3902 | 321 | 11.16 | 160.00 | |
3 | Cancer and Metastasis Reviews | journal | 2.107 Q1 | 167 | 54 | 220 | 8522 | 1887 | 203 | 8.04 | 157.81 | |
4 | Experientia supplementum (2012) | journal | 0.321 | 11 | 26 | 40 | 4052 | 62 | 0 | 1.26 | 155.85 | |
5 | MedComm | journal | 25 | 82 | 89 | 11755 | 701 | 75 | 7.88 | 143.35 | ||
6 | Blood Reviews | journal | 2.803 Q1 | 112 | 60 | 198 | 7100 | 1803 | 197 | 7.59 | 118.33 | |
7 | Journal of Hematology and Oncology | journal | 6.046 Q1 | 144 | 169 | 497 | 18270 | 11261 | 433 | 20.94 | 108.11 | |
8 | Critical Reviews in Oncology/Hematology | journal | 1.510 Q1 | 144 | 203 | 644 | 20544 | 3838 | 632 | 5.90 | 101.20 | |
9 | Exploration of Targeted Anti-tumor Therapy | journal | 10 | 52 | 66 | 5025 | 125 | 64 | 1.89 | 96.63 | ||
10 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q3 | 52 | 35 | 97 | 3255 | 293 | 92 | 2.72 | 93.00 | |
11 | Ca-A Cancer Journal for Clinicians | journal | 86.091 Q1 | 211 | 41 | 118 | 3509 | 30712 | 85 | 303.55 | 85.59 | |
12 | Current Cancer Drug Targets | journal | 0.687 Q3 | 103 | 69 | 228 | 5875 | 726 | 219 | 2.97 | 85.14 | |
13 | Cancer Treatment Reviews | journal | 3.589 Q1 | 164 | 94 | 281 | 7990 | 3603 | 280 | 11.89 | 85.00 | |
14 | Molecular Cancer | journal | 8.703 Q1 | 196 | 208 | 475 | 17628 | 16683 | 427 | 28.64 | 84.75 | |
15 | Oncology Reviews | journal | 0.861 Q2 | 31 | 9 | 64 | 717 | 235 | 63 | 3.05 | 79.67 | |
16 | Cellular oncology (Dordrecht) | journal | 1.408 Q1 | 58 | 82 | 229 | 6314 | 1399 | 226 | 6.27 | 77.00 | |
17 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.705 Q2 | 112 | 16 | 91 | 1231 | 209 | 86 | 2.22 | 76.94 | |
18 | Nature Reviews Cancer | journal | 20.977 Q1 | 505 | 111 | 325 | 8402 | 10652 | 174 | 37.68 | 75.69 | |
19 | NAR Cancer | journal | 17 | 44 | 90 | 3329 | 432 | 89 | 4.85 | 75.66 | ||
20 | Expert Review of Anticancer Therapy | journal | 0.841 Q2 | 85 | 125 | 346 | 9386 | 1087 | 306 | 2.84 | 75.09 | |
21 | Journal of Cancer Metastasis and Treatment | journal | 0.619 Q3 | 16 | 49 | 202 | 3675 | 477 | 193 | 1.82 | 75.00 | |
22 | Cancers | journal | 1.312 Q1 | 133 | 6215 | 12215 | 464490 | 66962 | 11977 | 5.11 | 74.74 | |
23 | Trends in Cancer | journal | 3.581 Q1 | 90 | 106 | 322 | 7840 | 3674 | 310 | 11.31 | 73.96 | |
24 | Cancer Treatment and Research | journal | 0.131 Q4 | 65 | 26 | 101 | 1917 | 243 | 1 | 0.74 | 73.73 | |
25 | Current Oncology Reports | journal | 1.314 Q1 | 77 | 175 | 382 | 12892 | 2145 | 379 | 4.79 | 73.67 | |
26 | Current Treatment Options in Oncology | journal | 1.118 Q2 | 66 | 119 | 300 | 8715 | 1486 | 297 | 4.17 | 73.24 | |
27 | Hematology/Oncology Clinics of North America | journal | 0.866 Q2 | 95 | 90 | 271 | 6577 | 730 | 234 | 2.00 | 73.08 | |
28 | Seminars in Radiation Oncology | journal | 1.389 Q1 | 103 | 48 | 128 | 3416 | 616 | 119 | 3.55 | 71.17 | |
29 | Current Hematologic Malignancy Reports | journal | 0.914 Q2 | 44 | 31 | 162 | 2200 | 569 | 162 | 3.06 | 70.97 | |
30 | Experimental Hematology and Oncology | journal | 1.908 Q1 | 42 | 106 | 126 | 7331 | 969 | 107 | 8.64 | 69.16 | |
31 | Hepatoma Research | journal | 0.385 Q3 | 14 | 39 | 206 | 2697 | 314 | 193 | 1.60 | 69.15 | |
32 | Biologics: Targets and Therapy | journal | 1.176 Q1 | 47 | 18 | 69 | 1241 | 349 | 69 | 4.29 | 68.94 | |
33 | Cancer Cell International | journal | 1.145 Q2 | 80 | 408 | 1569 | 28061 | 8859 | 1567 | 5.52 | 68.78 | |
34 | Cancer Letters | journal | 2.088 Q1 | 216 | 376 | 1321 | 25485 | 11923 | 1303 | 9.11 | 67.78 | |
35 | Molecular Oncology | journal | 1.778 Q1 | 113 | 232 | 601 | 15586 | 4099 | 586 | 6.79 | 67.18 | |
36 | International Journal of Oncology | journal | 1.116 Q2 | 139 | 152 | 661 | 10174 | 3674 | 660 | 4.90 | 66.93 | |
37 | Journal of the National Cancer Center | journal | 2.649 Q1 | 9 | 38 | 19 | 2525 | 179 | 16 | 9.42 | 66.45 | |
38 | Immuno-Oncology and Technology | journal | 0.691 Q3 | 10 | 8 | 33 | 524 | 67 | 25 | 1.65 | 65.50 | |
39 | Cancer journal (Sudbury, Mass.) | journal | 0.880 Q2 | 102 | 70 | 217 | 4548 | 487 | 198 | 1.93 | 64.97 | |
40 | Journal of Experimental and Clinical Cancer Research | journal | 2.413 Q1 | 120 | 330 | 1058 | 21141 | 11401 | 1056 | 9.37 | 64.06 | |
41 | Molecular Therapy - Oncolytics | journal | 1.339 Q1 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | |
42 | Nature Reviews Clinical Oncology | journal | 14.809 Q1 | 217 | 130 | 442 | 8154 | 9588 | 202 | 24.36 | 62.72 | |
43 | Oncology Research | journal | 0.658 Q3 | 76 | 24 | 249 | 1456 | 804 | 240 | 2.19 | 60.67 | |
44 | Seminars in Oncology | journal | 1.464 Q1 | 145 | 60 | 140 | 3615 | 700 | 129 | 3.72 | 60.25 | |
45 | Cancer Biology and Medicine | journal | 1.466 Q1 | 62 | 128 | 236 | 7632 | 1503 | 236 | 6.35 | 59.63 | |
46 | Best Practice and Research in Clinical Haematology | journal | 0.968 Q2 | 81 | 44 | 151 | 2582 | 382 | 142 | 2.04 | 58.68 | |
47 | Cancer Innovation | journal | 4 | 20 | 0 | 1148 | 0 | 0 | 0.00 | 57.40 | ||
48 | Oncologie | journal | 0.138 Q4 | 12 | 54 | 83 | 3089 | 53 | 81 | 0.74 | 57.20 | |
49 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | |
50 | Clinical and Experimental Metastasis | journal | 1.125 Q2 | 109 | 75 | 158 | 4276 | 699 | 145 | 3.79 | 57.01 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®